Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.72B |
| 2 |
Meta Platforms (Facebook)
META
|
+$660M |
| 3 |
Micron Technology
MU
|
+$605M |
| 4 |
Mastercard
MA
|
+$497M |
| 5 |
Tesla
TSLA
|
+$495M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.33B |
| 2 |
Visa
V
|
+$1.26B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 4 |
Lam Research
LRCX
|
+$699M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$681M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 79.37% |
| 2 | Technology | 4.49% |
| 3 | Healthcare | 2.99% |
| 4 | Financials | 2.85% |
| 5 | Industrials | 2.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5476
PUT
Twist Bioscience
TWST
$11.1B
| $2.63M | ﹤0.01% |
55,400
+23,200
| +72% | +$1.04M |
2020 Q2
23 quarters
|
|
5477
CALL
iShares Russell 3000 ETF
IWV
$20.6B
| $2.63M | ﹤0.01% |
7,100
+2,100
| +42% | +$812K |
2024 Q4
5 quarters
|
|
|
IDYN
5478
iShares International Equity Factor Rotation Active ETF
IDYN
$108M
| $2.63M | ﹤0.01% |
91,236
-365,922
| -80% | -$10.9M |
2025 Q4
1 quarter
|
|
5479
Angel Oak Income ETF
CARY
$1.44B
| $2.63M | ﹤0.01% |
+126,442
| New | +$2.65M |
2026 Q1
0 quarters
|
|
5480
First Trust Nasdaq Bank ETF
FTXO
$251M
| $2.63M | ﹤0.01% |
72,593
+47,439
| +189% | +$1.79M |
2025 Q4
1 quarter
|
|
5481
CALL
iShares Russell Mid-Cap ETF
IWR
$56.6B
| $2.63M | ﹤0.01% |
27,000
-7,900
| -23% | -$789K |
2020 Q1
24 quarters
|
|
5482
PUT
SiTime
SITM
$21.4B
| $2.62M | ﹤0.01% |
7,600
-19,500
| -72% | -$7.17M |
2021 Q3
18 quarters
|
|
5483
PUT
Wave Life Sciences
WVE
$694M
| $2.62M | ﹤0.01% |
362,000
-430,300
| -54% | -$5.61M |
2023 Q4
9 quarters
|
|
|
ALMS
5484
PUT
Alumis Inc
ALMS
$897M
| $2.62M | ﹤0.01% |
119,100
+97,600
| +454% | +$2.44M |
2025 Q2
3 quarters
|
|
|
SBR
5485
Sabine Royalty Trust
SBR
$1.05B
| $2.62M | ﹤0.01% |
34,795
-4,092
| -11% | -$292K |
2025 Q1
4 quarters
|
|
|
CRESY
5486
Cresud
CRESY
$860M
| $2.62M | ﹤0.01% |
206,025
+30,068
| +17% | +$365K |
2025 Q2
3 quarters
|
|
5487
PUT
Structure Therapeutics
GPCR
$1.96B
| $2.62M | ﹤0.01% |
54,300
-500
| -0.9% | -$34.2K |
2023 Q4
9 quarters
|
|
|
TIGR
5488
PUT
UP Fintech Holding
TIGR
$813M
| $2.62M | ﹤0.01% |
415,200
-335,000
| -45% | -$2.73M |
2020 Q3
22 quarters
|
|
5489
PUT
IDEAYA Biosciences
IDYA
$3.53B
| $2.62M | ﹤0.01% |
78,500
+59,600
| +315% | +$2M |
2025 Q4
1 quarter
|
|
5490
Calvert US Large-Cap Diversity, Equity and Inclusion Index ETF
CDEI
$19.1M
| $2.61M | ﹤0.01% |
+33,694
| New | +$2.74M |
2026 Q1
0 quarters
|
|
5491
PUT
Blackstone Mortgage Trust
BXMT
$1.9B
| $2.61M | ﹤0.01% |
136,400
-234,400
| -63% | -$4.52M |
2019 Q4
25 quarters
|
|
5492
PUT
Alpha Pro Tech
APT
$61.1M
| $2.61M | ﹤0.01% |
588,200
+495,000
| +531% | +$2.43M |
2020 Q1
24 quarters
|
|
5493
CALL
Teladoc Health
TDOC
$1.05B
| $2.61M | ﹤0.01% |
479,000
-290,400
| -38% | -$1.63M |
2015 Q4
41 quarters
|
|
|
LADR
5494
Ladder Capital
LADR
$1.1B
| $2.61M | ﹤0.01% |
267,157
-100,529
| -27% | -$1.06M |
2024 Q3
6 quarters
|
|
5495
CALL
ProShares UltraShort S&P500
SDS
$356M
| $2.61M | ﹤0.01% |
34,680
-58,720
| -63% | -$4.08M |
2016 Q3
38 quarters
|
|
|
VMRK
5496
CALL
Vivmark Residential
VMRK
$46.7B
| $2.61M | ﹤0.01% |
44,100
+27,100
| +159% | +$1.67M |
2018 Q1
32 quarters
|
|
|
SW
5497
CALL
Smurfit Westrock
SW
$22.2B
| $2.61M | ﹤0.01% |
65,400
-17,400
| -21% | -$750K |
2024 Q3
6 quarters
|
|
5498
Vanguard Total Corporate Bond ETF
VTC
$1.65B
| $2.6M | ﹤0.01% |
33,882
+27,149
| +403% | +$2.11M |
2024 Q2
7 quarters
|
|
5499
Adicet Bio
ACET
$58.5M
| $2.6M | ﹤0.01% |
381,823
+274,009
| +254% | +$2.05M |
2021 Q4
17 quarters
|
|
5500
Core Laboratories
CLB
$473M
| $2.6M | ﹤0.01% |
154,800
+117,867
| +319% | +$2.11M |
2017 Q2
35 quarters
|
|
Similar funds
Citadel Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Citadel Advisors held 14,860 positions worth $618B, down 7.1% from $666B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Citadel Advisors's Q1 2026 filing shows 2,347 new, 5,138 increased, 5,286 reduced and 2,003 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M. The largest sale was Amazon, an estimated $1.33B.
By sector, the portfolio is most concentrated in Miscellaneous at 79% of assets, down from 80% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q1 2026 buy was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $2.72B increase.
- Citadel Advisors's biggest Q1 2026 reduction was Amazon, cutting an estimated $1.33B.
- Citadel Advisors fully exited CyberArk in Q1 2026, selling an estimated $305M.
- Citadel Advisors's ten largest holdings make up 22% of its $618B portfolio in Q1 2026.
- Citadel Advisors opened 2,347 new positions and closed 2,003 in Q1 2026.
- Citadel Advisors's portfolio value fell 7.1% quarter-over-quarter to $618B.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.